Hantavirus has never gone away. But four converging forces are pulling it back into the news cycle in 2026. Every driver below is anchored in a published source.
The 1992–1993 El Niño produced an unusually wet winter in the American Southwest. The pinyon nut crop exploded. Deer-mouse populations rose roughly tenfold. The first North American hantavirus outbreak followed within months. Recent ENSO cycles in 2023–2024 produced similar conditions.
The 2018–2019 Epuyén outbreak in Argentina re-confirmed what the 1996 El Bolsón cluster first documented: Andes hantavirus spreads between people in close quarters. Of all hantaviruses on Earth, it remains the only one with this property.
Suburban expansion creates more edge habitat — the interface between human shelters and wild rodent populations. Cleaning out garages, sheds, attics and stored caravans is the textbook hantavirus exposure scenario. CDC prevention guidance has expanded as case counts crept up.
Sin Nombre was identified in 1993. As of 2026 no licensed human vaccine exists in the United States or United Kingdom. Inovio's INO-4500/INO-4700 DNA-vaccine candidates have only reached early-phase trials. When a virus kills more than one in three and only a few hundred per year, the funding model breaks.